There are currently 60 active clinical trials seeking participants for Pregnancy research studies. The states with the highest number of trials for Pregnancy participants are California, New York, Pennsylvania and North Carolina.
Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia
Recruiting
This study's primary purpose is to determine the relationship between aspirin metabolism and markers of metabolic dysfunction among patients at risk for preeclampsia. Further, we will add an exploratory outcome to evaluate the neonatal body composition and anthropometric data to better understand neonatal impacts of maternal metabolic dysfunction.
Gender:
FEMALE
Ages:
Between 18 years and 45 years
Trial Updated:
01/24/2025
Locations: University of Tennessee Medical Center, Knoxville, Tennessee
Conditions: Preeclampsia, Preeclampsia (PE), Preeclampsia (PE) Risk, Obesity and Obesity-related Medical Conditions, Pregnancy, Pregnancy Complications, Gestational Diabetes, Gestational Diabetes Mellitus in Pregnancy, Gestational Complications
Grocery Delivery and Healthy Weight Gain Among Low-income Pregnant Young Women
Recruiting
This project will increase knowledge about how a simple intervention, grocery delivery, impacts weight gain and diet among low-income pregnant young women. Results can then be used to support other pregnant young women.
Gender:
FEMALE
Ages:
Between 14 years and 26 years
Trial Updated:
01/20/2025
Locations: The University of Michigan, Ann Arbor, Michigan
Conditions: Pregnancy, Weight Gain
External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy
Recruiting
This online registry aims to understand the potential benefits and safety of external trigeminal nerve stimulation for the treatment of migraine in pregnant women. Women do not need to use external trigeminal nerve stimulation or any other form of migraine treatment to participate in the registry. The main question it aims to answer is: Is external trigeminal nerve stimulation a safe and effective option for migraine treatment during and after pregnancy? There are no required changes in migra... Read More
Gender:
FEMALE
Ages:
Between 18 years and 44 years
Trial Updated:
01/17/2025
Locations: https://public.smart-trial.co/#/public/649d77f0e8f8d0fb993d0c61/6626f6a04f0a3c7dd0860e14/662726d84f0a3c7dd08aeaa0/signup?lang=en-us&enforceLanguage=true, Darien, Connecticut
Conditions: Pregnancy, Migraine, Headache, Postpartum, Depression, Anxiety
Kesimpta (Ofatumumab) Pregnancy Registry
Recruiting
The Kesimpta Pregnancy Registry is an observational, exposure cohort designed study to examine pregnancy and infant outcomes in women and infants who are exposed to Kesimpta (ofatumumab) during pregnancy to treat MS.
Gender:
ALL
Ages:
Between 18 years and 100 years
Trial Updated:
01/12/2025
Locations: University of California San Diego OTIS, La Jolla, California
Conditions: Multiple Sclerosis, Pregnancy
Mitigating Response to Stressors in Pregnant Women
Recruiting
Stress-induced pregnancy complications are significant contributors to preterm labor as well as maternal and perinatal morbidity and mortality. The goals of this study are two folds: first it aims to capture the pregnant woman's journey to seek and receive prenatal care. Second, this study aims to develop models that 1) assess the adverse health and biological effects of social factors on pregnant women who experience repeated or chronic stress, 2) address how stress can be mitigated in pregnant... Read More
Gender:
FEMALE
Ages:
Between 21 years and 37 years
Trial Updated:
01/06/2025
Locations: Nova Southeastern University, Davie, Florida
Conditions: Pregnancy
Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
Recruiting
The primary objective of this study is to describe the frequency and characteristics of pregnancy outcomes and maternal complications among participants exposed to Ultomiris and to describe the frequency and characteristics of selected fetal/neonatal/infant outcomes in utero, at birth, and through 1 year of age after exposure in utero or via breastmilk.
Gender:
FEMALE
Ages:
All
Trial Updated:
01/06/2025
Locations: North American call center (NACC), Boston, Massachusetts
Conditions: Ultomiris-exposed Pregnant/ Postpartum, Pregnancy, Paroxysmal Nocturnal Hemoglobinuria (PNH), Atypical Hemolytic Uremic Syndrome (aHUS), Generalized Myasthenia Gravis (gMG), Neuromyelitis Optica Spectrum Disorder (NMOSD)
Oral Iron Supplementation on Alternate Vs. Consecutive Days for Iron Deficiency Anemia in Pregnancy
Recruiting
This will be a randomized clinical trial. Enrolled subjects will be randomized (1:1) into two study arms to receive either daily (Group 1) or alternate day (Group 2) supplementation with one oral pill containing ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill.
Gender:
FEMALE
Ages:
Between 18 years and 45 years
Trial Updated:
12/10/2024
Locations: Southern Illinois University School of Medicine, Springfield, Illinois
Conditions: Iron-deficiency Anemia (IDA), Pregnancy
Pregnancies Complicated by Fetal Anomalies
Recruiting
The focus of this research is to create a repository of ultrasonographic images and their corresponding medical data from pregnant women (the mothers of the fetuses that are imaged), focusing on fetal anomalies. These women will visit the obstetrical clinics at Regional One Health and the Le Bonheur Fetal Center.
Gender:
ALL
Ages:
Between 1 minute and 50 years
Trial Updated:
12/04/2024
Locations: LeBonheur Children's Hospital, Memphis, Tennessee +4 locations
Conditions: Pregnancy, Congenital Abnormalities
UCLA Perinatal Biospecimen Repository
Recruiting
The purpose of this investigator-initiated prospective observational cohort study is to establish the new UCLA Perinatal Biospecimen Repository (Perinatal Repository) for collection, storage, and distribution of the human data and biospecimens of the participants with perinatal pathology. The secure and shared high-quality resource of clinical data and biological specimens (Repository Materials), across pregnancy pathology related to research protocols at the Afshar's Lab will be created. Core v... Read More
Gender:
ALL
Ages:
1 minute and above
Trial Updated:
12/03/2024
Locations: Afshar Lab, Department of Obstetrics & Gynecology, UCLA, Los Angeles, California
Conditions: Pregnancy, High-Risk Pregnancy
Prenatal Starting Early Program mHealth
Recruiting
The purpose of this interventional trial is to test the efficacy of the remote delivery of the StEP:Prenatal intervention compared to standard prenatal care in pregnant individuals planning to receive prenatal and pediatric care at Bellevue Hospital. The primary aims are to determine the efficacy of the remotely delivered StEP:Prenatal intervention on diet, lifestyle behaviors, social determinants of health (SDoH), and pregnancy outcomes.
Gender:
FEMALE
Ages:
Between 18 years and 99 years
Trial Updated:
12/02/2024
Locations: NYC Health + Hospitals/Bellevue, New York, New York
Conditions: Pregnancy
Enhancing Care & Outcomes for Patients During the First Postpartum Year
Recruiting
The United States is in the midst of a maternal mortality and morbidity crisis, with more than half of maternal deaths occurring within the first postpartum year. Patients with hypertensive disorders of pregnancy (HDP) and diabetes have been found to be particularly high-risk, as they have a significantly increased risk for the development of cardiovascular disease in the long-term postpartum period. Traditionally, postpartum care has consisted of a single office visit at six weeks postpartum. R... Read More
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
11/22/2024
Locations: University of Maryland, Baltimore, Baltimore, Maryland
Conditions: Postpartum Period, Pregnancy, Hypertension, Pregnancy Induced
Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation
Recruiting
The PLANET Study aims to determine the impact of microplastics on intestinal inflammation and gut microbiome in order to understand the role of this pollutant on the risk of developing inflammatory bowel disease (IBD) as well as other diseases. With this information, the researchers hope to characterize better the role of environmental pollutants on IBD and develop novel strategies towards prevention.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/22/2024
Locations: Icahn School of Medicine at Mount Sinai, New York, New York
Conditions: Crohns Disease, Pregnancy, Inflammatory Bowel Disease